Hedwig M Blommestein

14PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 05, 2026
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

|Feb 22, 2025
Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma.

Saskia de Groot, Hedwig M Blommestein, Brenda Leeneman

|Nov 28, 2024
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer.

Gabe S Sonke, Annemiek van Ommen-Nijhof, Noor Wortelboer

|Oct 11, 2023
Treatment sequences and drug costs from diagnosis to death in multiple myeloma.

M R Seefat, D G J Cucchi, K Groen

|May 28, 2023
Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer.

Marianne Luyendijk, Agnes Jager, Sanne M Buijs

|May 03, 2023
Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease.

Brenda Leeneman, Hedwig M Blommestein, Annemieke van Dongen-Leunis

Pageof 3

Frequent Collaborators

4 joint publications

Agnes Jager

3 joint publications

Sabine Siesling

3 joint publications

Carin A Uyl-de Groot

3 joint publications

Gabe S Sonke